Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110326324 | 11032632 | 4 | F | 2009 | 20160701 | 20150415 | 20160705 | EXP | US-009507513-1504USA015061 | MERCK | 0.00 | M | Y | 0.00000 | 20160705 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110326324 | 11032632 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
110326324 | 11032632 | 2 | SS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
110326324 | 11032632 | 3 | SS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG QD | 20788 | 1 | MG | FILM-COATED TABLET | QD | ||||||
110326324 | 11032632 | 4 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
110326324 | 11032632 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110326324 | 11032632 | 1 | Alopecia |
110326324 | 11032632 | 4 | Blood cholesterol increased |
110326324 | 11032632 | 5 | Dyslipidaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110326324 | 11032632 | DS |
110326324 | 11032632 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110326324 | 11032632 | Anxiety | |
110326324 | 11032632 | Back pain | |
110326324 | 11032632 | Blood pressure increased | |
110326324 | 11032632 | Brain injury | |
110326324 | 11032632 | Breast enlargement | |
110326324 | 11032632 | Depression | |
110326324 | 11032632 | Disturbance in attention | |
110326324 | 11032632 | Dysgeusia | |
110326324 | 11032632 | Ejaculation disorder | |
110326324 | 11032632 | Endocrine disorder | |
110326324 | 11032632 | Erectile dysfunction | |
110326324 | 11032632 | Genital hypoaesthesia | |
110326324 | 11032632 | Haematuria | |
110326324 | 11032632 | Hormone level abnormal | |
110326324 | 11032632 | Hypothyroidism | |
110326324 | 11032632 | Insomnia | |
110326324 | 11032632 | Libido decreased | |
110326324 | 11032632 | Penis disorder | |
110326324 | 11032632 | Sexual dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110326324 | 11032632 | 1 | 200904 | 201004 | 0 | |
110326324 | 11032632 | 2 | 2011 | 2012 | 0 | |
110326324 | 11032632 | 3 | 201109 | 201205 | 0 | |
110326324 | 11032632 | 4 | 2004 | 0 |